HRTS
Tema Cardiovascular and Metabolic ETF·Financial Services
33.80
1.258%(−0.43)
Market ClosedLast Updated: — ET
52W L: $26.5052W H: $36.65
HRTS NEWS
defenseworld.net
Mar 4
Tema Heart & Health ETF (NASDAQ:HRTS) Shares Down 1.5% – Time to Sell?
Tema Heart and Health ETF (NASDAQ: HRTS - Get Free Report) shares traded down 1.5% on Tuesday. The stock traded as low as $35.00 and last traded at $35.21. 6,130 shares traded hands during trading, a decline of 30% from the average session volume of 8,784 shares. The stock had previously closed at $35.75. Tema
businesswire.com
Feb 18
Tema Appoints ETF Industry Leader Steve Munroe as President
NEW YORK--(BUSINESS WIRE)--Tema ETFs (“Tema”), a leader in institutional-quality and actively managed exchange-traded funds, today announced the appointment of Steve Munroe as President. In this role, Mr. Munroe will partner with Tema Founder and CEO Maurits Pot and the firm's leadership team to accelerate the company's next phase of growth. He will oversee branding, marketing, distribution, and product strategy as Tema continues to gain momentum—raising more than $1 billion in net new assets o.
etftrends.com
Jan 12
New Year, New Strategy: Navigating Weight Loss ETFs
With the start of 2026, the annual focus on weight loss resolutions presents a timely opportunity for financial advisors to discuss the investment potential of GLP-1 agonists with their clients. This class of drugs has fundamentally altered the healthcare sector's growth projections.
